secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0000950170-25-007314
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences grants 117K options to execs and directors at $3.33 strike
------------------------------------------------------------------------

- CEO Andrew Simpson and COO Mark Hilz each receive 45,000 options; CFO Danielle Watson receives 9,000.
- Non-employee directors Brian Szymczak, Bruce Brent, and David R. Wells each receive 6,000 options.
- All options have exercise price of $3.33 per share; executive options vest over 3 years with 1-year cliff.
- Director options vested 1/4 immediately, remainder quarterly; vesting may accelerate on FDA clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017025007314/0000950170-25-007314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017025007314/hscs-20250116.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-007314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer